| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |